Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.

Kaas A, Andersen ML, Fredheim S, Hougaard P, Buschard K, Petersen JS, de Beaufort C, Robertson KJ, Hansen L, Mortensen HB, Nielsen LB; Hvidoere Study Group on childhood diabetes.

Pediatr Diabetes. 2012 Feb;13(1):51-8. doi: 10.1111/j.1399-5448.2011.00812.x. Epub 2011 Nov 27.

PMID:
22118630
2.

New definition for the partial remission period in children and adolescents with type 1 diabetes.

Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H, Bjoerndalen H, de Beaufort C, Chiarelli F, Danne T, Schoenle EJ, Aman J; Hvidoere Study Group on Childhood Diabetes.

Diabetes Care. 2009 Aug;32(8):1384-90. doi: 10.2337/dc08-1987. Epub 2009 May 12.

3.

Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.

Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi M, Bognetti E, Meschi F, Bosi E, Chiumello G, Bonifacio E.

Diabet Med. 1998 Oct;15(10):844-50.

PMID:
9796885
4.

Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.

Pörksen S, Nielsen LB, Kaas A, Kocova M, Chiarelli F, Orskov C, Holst JJ, Ploug KB, Hougaard P, Hansen L, Mortensen HB; Hvidøre Study Group on Childhood Diabetes.

J Clin Endocrinol Metab. 2007 Aug;92(8):2910-6. Epub 2007 May 22.

PMID:
17519307
5.

Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.

Asmar M, Højberg PV, Deacon CF, Hare K, Holst JJ, Madsbad S.

Regul Pept. 2010 Feb 25;160(1-3):175-80. doi: 10.1016/j.regpep.2009.12.004. Epub 2010 Jan 13.

PMID:
20005261
6.

The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes.

Nielsen LB, Pörksen S, Andersen ML, Fredheim S, Svensson J, Hougaard P, Vanelli M, Åman J, Mortensen HB, Hansen L; Hvidoere Study Group on Childhood Diabetes.

BMC Med Genet. 2011 Mar 23;12:41. doi: 10.1186/1471-2350-12-41.

7.

Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1.

Silbernagel G, Renner W, Grammer TB, Hügl SR, Bertram J, Kleber ME, Hoffmann MM, Winkelmann BR, März W, Boehm BO.

Diabetes Metab Res Rev. 2011 Jul;27(5):499-505. doi: 10.1002/dmrr.1194.

PMID:
21384500
8.

Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies.

Snorgaard O, Kjems LL, Røder ME, Hartling SG, Dinesen B, Binder C.

Diabetes Care. 1996 Feb;19(2):146-50.

PMID:
8718435
9.

Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.

Mortensen HB, Swift PG, Holl RW, Hougaard P, Hansen L, Bjoerndalen H, de Beaufort CE, Knip M; Hvidoere Study Group on Childhood Diabetes.

Pediatr Diabetes. 2010 Jun;11(4):218-26. doi: 10.1111/j.1399-5448.2009.00566.x. Epub 2008 Aug 25.

PMID:
19708904
10.

Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.

Truyen I, De Pauw P, Jørgensen PN, Van Schravendijk C, Ubani O, Decochez K, Vandemeulebroucke E, Weets I, Mao R, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2005 Nov;48(11):2322-9. Epub 2005 Oct 7.

PMID:
16211374
11.

Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.

Böber E, Dündar B, Büyükgebiz A.

J Pediatr Endocrinol Metab. 2001 Apr;14(4):435-41.

PMID:
11327378
12.

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC; Hvidøre Study Group on Childhood Diabetes.

Diabetes. 2008 Apr;57(4):929-37. doi: 10.2337/db07-1697. Epub 2008 Feb 25.

13.

Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.

Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W.

Diabetes Care. 1998 Nov;21(11):1925-31.

PMID:
9802745
14.

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA.

Diabetes Care. 1996 Jun;19(6):580-6.

PMID:
8725855
15.

Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.

Max Andersen ML, Hougaard P, Pörksen S, Nielsen LB, Fredheim S, Svensson J, Thomsen J, Vikre-Jørgensen J, Hertel T, Petersen JS, Hansen L, Mortensen HB.

Pediatr Diabetes. 2014 Nov;15(7):469-76. doi: 10.1111/pedi.12208.

PMID:
25287319
16.

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.

Nauck MA, Wollschläger D, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Willms B.

Diabetologia. 1996 Dec;39(12):1546-53.

PMID:
8960841
17.

Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.

Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.

J Pediatr Endocrinol Metab. 2002 Jan;15(1):59-67.

PMID:
11822582
18.

The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.

Fredheim S, Andersen ML, Pörksen S, Nielsen LB, Pipper C, Hansen L, Holst JJ, Thomsen J, Johannesen J, Mortensen HB, Svensson J.

Diabetologia. 2015 Apr;58(4):828-34. doi: 10.1007/s00125-014-3486-3. Epub 2014 Dec 27.

PMID:
25541633
19.

Decreased active GLP-1 response following large test meal in patients with type 1 diabetes using bolus insulin analogues.

Kamoi K, Shinozaki Y, Furukawa K, Sasaki H.

Endocr J. 2011;58(10):905-11. Epub 2011 Aug 30.

20.

[Factors affecting C-peptide level during the first year of type 1 diabetes in children].

Zmysłowska A, Szadkowska A, Andrzejewski W, Wegner O, Wyka K, Młynarski W, Bodalski J.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):103-11. Polish.

PMID:
15504313

Supplemental Content

Support Center